All Posts By

Merel

Amsterdam UMC and Nico.lab awarded TKI-PPP subsidy to improve stroke treatment planning through AI built in collaboration with Google Cloud

By | News

Amsterdam UMC and Nico.lab received €800.000 from the Dutch Ministry of Economic Affairs. This subsidy was awarded to develop Artificial Intelligence (AI) methods to accelerate Magnetic Resonance (MR) imaging and analysis in stroke victims using the Google Cloud Platform. The project aims to enable hospitals to acquire brain scans ten times faster, making MR suitable for the acute clinical setting where minutes matter. With this grant, the consortium aims to improve the complex decision-making in stroke and shorten the time that is needed to initiate appropriate therapy, thereby improving the quality of life after stroke.

Fast diagnosis and treatment is key when suffering a stroke to prevent irreversible cell death and concomitant brain damage. CT imaging has been the predominant modality of choice for diagnosis and treatment planning, as it is fast, inexpensive and readily available. Its main limitation, however, is the limited sensitivity in the hyperacute setting. Manifestation of CT features is a process lasting several hours, making evaluation of CT scans difficult. MR is currently only scarcely used in stroke imaging. 

The project STAIRS – Stroke treatment decision support by Artificial Intelligence for analysis of MR images – was established to investigate and develop novel AI techniques to accelerate MR imaging, and enhance its interpretation. Ten times accelerated MRI imaging and robust AI analysis will be developed and tested in the North-Holland, the Netherlands environment to demonstrate a short door-to-treatment time for patients. 

The consortium partners combine experience and expertise to lead the project and transform MR imaging in stroke. Amsterdam UMC, a world-leading stroke center, together with two other Dutch Academic Medical centers initiated and executed the renowned MR CLEAN trial that revolutionized stroke treatment and has extensive knowledge on stroke and MR imaging as such. Nico.lab successfully developed AI algorithms for CT imaging, and has a strong skill set in utilizing advanced AI to tackle medical imaging problems. Google Cloud Platform offers high-speed data access, as well as dedicated High Performance Computing resources, needed to enable MR image analysis by AI in the cloud. The company Qlouder aims at delivering cloud solutions to their partners.

Matthan Caan, assistant professor Amsterdam UMC: “The objective of STAIRS is improving AI-supported treatment planning of acute ischemic stroke based on MR imaging as an alternative to CT, enhancing efficiency of AI methods and exploiting hardware opportunities to its max. This AMC TKI-PPP subsidy allows us to take significant steps to improving decision-making in acute stroke”

Marketing manager (part-time)

By | Job openings

We are looking for a part-time Marketing Manager (expected 8 – 12 hours per week) who will lead the marketing campaigns for Nico.lab, helping us with our publicity.

We do not require a background in marketing, but experience is a plus. We welcome enthusiastic and driven students looking for a creative and worthwhile part time job. You understand our product and technology, and interact closely with our team to translate our work into interesting and exciting press articles. You must be comfortable using social media platforms and engaging with relevant technical and/or medical news sites, and you have excellent written English skills

Our focus: Using artificial intelligence to improve the lives of stroke patients by ensuring they get the best treatment possible, as soon as possible. Interested? Contact us at jobs@nico-lab.com.

Job responsibilities
  • Writing and publishing articles on Nico.lab’s social media accounts and news sites
  • Creating a wide range of marketing material
  • Coordinating marketing campaigns in line with sales activities and Nico.lab’s focus
  • Stay on top of research and developments concerning stroke
What we require
  • Strong communication skills
  • Must be fluent in English writing
  • Creative outlook
  • Interest in technology and improving patients lives
  • Confident and proactive
What we offer
  • Competitive salary
  • Being a key team member in a non-hierarchical organisation and having a real effect on the growth of the company
  • High-energy passionate colleagues who have come from all parts of the world to be a part of Nico.lab where movie nights, gamenights, camping trips and lots of Indian food are integral to our culture

 

Office Manager

By | Job openings

Looking for a versatile job in a young and fast-growing company in Amsterdam? Do you get energized by people and do you like rolling up your sleeves? Our team is looking for an Office Manager to join our team, so write us and we’ll get in touch!

The tasks of the Office Manager are versatile, dynamic and require a lot of responsibilities, such as:

  • Managing HR activities
  • Helping us designing our new awesome office
  • Ensuring the great working spirit remains
  • Financial administration
  • Contact person of the company

What we like:

  • You keep an overview of the organization and you consider yourself true a team player
  • You take initiative, think in solutions and have a creative spirit
  • You are punctual, organizational strong, and reliable
  • You can set priorities and structure things well
  • You have strong communication skills in both Dutch and English
  • You have a completed higher professional education
  • Experience within the medical field is a big plus

What we offer:

  • Opportunity to impact the healthcare worldwide
  • Challenging work experience in a fast-growing company with people from all over the globe
  • Work within a fun multidisciplinary team
  • Great office space with game nights, cocktail workshops, and other activities

Contact us at jobs@nico-lab.com and join our team! 

Press release: Nico.lab to Australian stock exchange and North America

By | News, Press Release

Amsterdam, August 27th 2018 – The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the Amsterdam UMC, the company has developed StrokeViewer®, a software product that significantly speeds up the diagnosis and treatment of strokes. Nico.lab now focuses on making StrokeViewer based on artificial intelligence (AI) available to more and more patients.

In the treatment of stroke, speed is crucial to limit the brain damage for the patient as much as possible; a patient quickly loses 27 healthy days of life per minute of treatment delay. Using AI, Nico.lab software analyzes brain scans to recognize and accurately assess stroke indicators. This all happens in a few minutes and thus considerably increases the chance of a positive result for the patient. In addition, the algorithm contains self-learning ability, and provides additional knowledge about this common disease and the functioning of the brain in such a serious situation.

This year, StrokeViewer is tested among 3,000 patients in various hospitals in the Netherlands and compared with the current method that has been used for years to diagnose a stroke. In other countries, the results achieved with StrokeViewer did not go unnoticed and Nico.lab recently won a European prize of half a million euros. The company has also been asked to participate in clinical trials in North America and Australia.

In order to meet the growing demands for StrokeViewer, new investments are necessary. The large Australian investment interest has resulted in Nico.lab attracting 3 million euros in investments from various investors. The investment round is part of an IPO in Australia. The IPO of Nico.lab is planned for early 2019. In addition to interest from Australia, there has also been interest from North America. Tech giants, including Google, Intel and HP have entered into a partnership with Nico.lab to prepare for the introduction of StrokeViewer on the US market in early 2019.

Merel Boers, Chief Research Officer at Nico.lab: “We are very pleased with the great interest in our product that combines the latest clinical research results with state-of-the-art AI technology. This movement shows that an impact can be made in health care. We want to work hard on further expanding StrokeViewer in the coming years to help more patients. ”

About Nico.lab

Nico.lab’s StrokeViewer uses Artificial Intelligence to shorten the time of determining the appropriate treatment for strokes to a few minutes, where it can sometimes take hours under the current method. StrokeViewer is now being rolled out in several Dutch hospitals. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC.

For more information please contact:
020 244 0852 / info@nico-lab.com

Nico.lab welcomes the new European General Data Protection Regulation (GDPR)

By | News

On May the 25th, the new General Data Protection Regulation (GDPR) comes into effect in the European Union. With the GDPR, the EU aims to protect the privacy and personal data of all citizens. The GDPR gives every individual primary control over his/her data, and holds all companies and organizations accountable for safe and legitimate processing of this data.

The GDPR has an important impact on the collection and processing of medical data. As a processor of sensitive medical data, Nico.lab welcomes and emphasizes compliance with the GDPR. Nico.lab incorporates security of StrokeViewer as one of its core values in the development of StrokeViewer, making StrokeViewer secure-by-design. Also, StrokeViewer only shows the necessary information for diagnostic purposes “by default”, and can be tailored per hospital. To ensure the utmost quality of our company Infomation Security Management System (ISMS), Nico.lab is supported by fore-front legal offices specialized in medical technology.

We are happy to answer any questions regarding privacy and security. Please send a message via our contact page. For further information regarding the GDPR, please read the information provided by the EU.

Visit Nico.lab at the European Stroke Organization Conference (ESOC) 2018

By | News

Nico.lab will be present at this year’s European Stroke Organization Conference (ESOC), held in Gothenburg, Sweden from May 16th-18th. The ESOC is one of the world’s leading conference on stroke, enabling learning, discussion, and exchange among European and international stroke specialists. Guided by the motto “The Voice of Stroke in Europe,” the Conference focuses about the latest clinical trials and developments in all areas of stroke management, treatment and prevention.  Visit us in the Exhibition hall at Booth 32b for a demo.

Press Release: Better treatment of stroke using artificial intelligence and blockchain

By | News, Press Release

Amsterdam, 21th March 2018  Every year about 50,000 people in the Netherlands are affected by a stroke. About 10,000 of these patients die and this number continues to increase. In order to reduce mortality, it is crucial to start the right treatment as soon as possible. Innovative technologies such as artificial intelligence and blockchain can help improve the outcome of a stroke.

For this purpose, Nico.lab, a spin-off of the Academisch Medisch Centrum (AMC) and developer of medical artificial intelligence, in collaboration with Tymlez, a provider of enterprise blockchain technology, have joined forces. Both companies are starting a pilot this month with a number of hospitals for superior treatment of strokes. They received funding from the Ministry of Economic Affairs and climate, which underlines the importance of these innovations.

Stroke is the leading cause of death after heart diseases and cancer in our country.

Rapid treatment crucial
Every hour that doctors are going to treat earlier, the number of patients who will recover without major problems increases by 15%. This means not only a significant improvement in the quality of life, but also a decrease in the economic cost of stroke. These amounts are currently more than EUR 1.7 billion per annum for the Netherlands.

A doctor can only choose the right treatment if there is a lot known about the problem in the patient’s brain, as with an infarction, the exact location of any blood clot. Viewing the scans by a doctor is however complex and time-consuming. Moreover, in practice, the analysis of the brain scan does not always lead to the correct diagnosis, which can have major consequences for the treatment and how the patient eventually recovers from the stroke. This also leads to unnecessarily high costs.

Artificial intelligence: fast and precise
The use of artificial intelligence in the treatment of stroke is an important improvement. These algorithms are, by applying the latest computer technology, not only fast, but also precise due to their learning ability. Nico.lab also makes the artificial intelligence solution available via the cloud, allowing hospitals to use it in a low-threshold way. These savings are estimated at over € 200 million on an annual basis, in light of the current costs of € 1.7 billion per year.

Because the computer for this artificial intelligence is not in their own hospital, the scans are encrypted and sent to Nico.lab via an internet connection at lightning speed. After analysis, the specialist receives the notification that he can log in to view the scans and the result itself. It is not important whether the neurologist is in a hospital or in a foreign hotel room while visiting a major medical conference or enjoying a day off at home.

Blockchain technology guarantees patient data confidentiality.
Naturally, confidentiality must be guaranteed when exchanging patient data. Because this is an exchange of privacy-sensitive data in a chain of medical professionals, the use of blockchain technology is the solution. Where many blockchains are known for cryptocurrency such as Bitcoin, the power of blockchain is security in data exchange. Tymlez ensures that all parts in the chain of people and machines are connected to the system via an unbreakable and safe process. The brain scans are then uniquely coded, so that they can only be shared with chain participants who are authorized to do so. The security of patient data is fully guaranteed in this way.

Note for editors:
For more information please contact:
Robert A. Kuipers, CEO Nico.lab: 06 1258 6631.

Nico.lab awarded PPP grant in co-operation with the AMC

By | News

The AMC Amsterdam and Nico.lab have been awarded the Health Holland 2017 PPP allowance for the BRAINS project. The PPP allowance is a Dutch program to provide a financial instrument to help consortia consisting of research organisations, knowledge institutes, companies, and health foundations to realise their innovative ideas.

BRAINS aims at analyzing radiological images to rapidly and reliably assess relevant features. BRAINS wishes to do so by implementing artificial intelligence for analysis of CT and MRI to accurately evaluate two key parameters: collateral capacity and ischemic tissue damage. These applications have the potential to assist adequate and fast treatment decisions, which allows the patient to be treated faster and more efficient, leading to a better outcome.